Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy
Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM...
Gespeichert in:
Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 1997-11, Vol.41 (11), p.2433-2438 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2438 |
---|---|
container_issue | 11 |
container_start_page | 2433 |
container_title | Antimicrobial Agents and Chemotherapy |
container_volume | 41 |
creator | VANHOVE, G. F GRIES, J.-M VEROTTA, D SHEINER, L. B COOMBS, R COLLIER, A. C BLASCHKE, T. F |
description | Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
doi_str_mv | 10.1128/aac.41.11.2433 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_164141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79403059</sourcerecordid><originalsourceid>FETCH-LOGICAL-a573t-42a632ded1d5bfc32a3a3211776feb09a9c1f578b65bdd3e90a720a85dbb272c3</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhi0EKkvhyg0pQogLzeLvxAcOq1UpSJW4wNma2E7jKolTO9nS_npcdrVqD4iTX3ued2bsMUJvCV4TQuvPAGbNSdZryhl7hlYEq7qUQsnnaIWxlCWvMX-JXqV0jfNeKHyCThSrCONyhZrz31NIS3RldGkKY3JFdD3MPsvOT6loQywS3Cx-hJ2PZ8W9t2G3WD-6swJGW9xDb_wMTT4o_FiYMGT511_MnYsw3b1GL1rok3tzWE_Rr6_nP7ffyssfF9-3m8sSRMXmklOQjFpniRVNaxgFBowSUlWydQ1WoAxpRVU3UjTWMqcwVBRDLWzT0Ioadoq-7PNOSzM4a9w4R-j1FP0A8U4H8PppZPSdvgo7TSQnnGT_x4M_hpvFpVkPPhnX9zC6sCRdKY4ZFuq_IJEid61kBtd70MSQUnTtsRmC9cP09Gaz1ZxkrR-mlw2f9gZIA9XXYYljfrF_0-8eX_iY_DDcHP9wiEMy0LcRRuPTEaNYcIFxxt7vsc5fdbc-Op2r6_yvHtf6Axdovdk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16517796</pqid></control><display><type>article</type><title>Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>VANHOVE, G. F ; GRIES, J.-M ; VEROTTA, D ; SHEINER, L. B ; COOMBS, R ; COLLIER, A. C ; BLASCHKE, T. F</creator><creatorcontrib>VANHOVE, G. F ; GRIES, J.-M ; VEROTTA, D ; SHEINER, L. B ; COOMBS, R ; COLLIER, A. C ; BLASCHKE, T. F</creatorcontrib><description>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/aac.41.11.2433</identifier><identifier>PMID: 9371346</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adult ; AIDS/HIV ; Anti-HIV Agents ; Anti-HIV Agents - blood ; Anti-HIV Agents - pharmacokinetics ; Anti-HIV Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Area Under Curve ; Biological and medical sciences ; CD4 Lymphocyte Count - drug effects ; Clinical Trial ; Clinical Trial, Phase II ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Female ; HIV Infections ; HIV Infections - drug therapy ; HIV Infections - immunology ; Humans ; Male ; Medical sciences ; Middle Aged ; Multicenter Study ; Pharmacology. Drug treatments ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S ; RNA, Viral - blood ; Saquinavir ; Saquinavir - blood ; Saquinavir - pharmacokinetics ; Saquinavir - therapeutic use ; Zalcitabine ; Zalcitabine - blood ; Zalcitabine - pharmacokinetics ; Zalcitabine - therapeutic use ; Zidovudine ; Zidovudine - blood ; Zidovudine - pharmacokinetics ; Zidovudine - therapeutic use</subject><ispartof>Antimicrobial Agents and Chemotherapy, 1997-11, Vol.41 (11), p.2433-2438</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a573t-42a632ded1d5bfc32a3a3211776feb09a9c1f578b65bdd3e90a720a85dbb272c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC164141/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC164141/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2054500$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9371346$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VANHOVE, G. F</creatorcontrib><creatorcontrib>GRIES, J.-M</creatorcontrib><creatorcontrib>VEROTTA, D</creatorcontrib><creatorcontrib>SHEINER, L. B</creatorcontrib><creatorcontrib>COOMBS, R</creatorcontrib><creatorcontrib>COLLIER, A. C</creatorcontrib><creatorcontrib>BLASCHKE, T. F</creatorcontrib><title>Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Anti-HIV Agents</subject><subject>Anti-HIV Agents - blood</subject><subject>Anti-HIV Agents - pharmacokinetics</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>CD4 Lymphocyte Count - drug effects</subject><subject>Clinical Trial</subject><subject>Clinical Trial, Phase II</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>HIV Infections</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - immunology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multicenter Study</subject><subject>Pharmacology. Drug treatments</subject><subject>Randomized Controlled Trial</subject><subject>Research Support, Non-U.S. Gov't</subject><subject>Research Support, U.S. Gov't, P.H.S</subject><subject>RNA, Viral - blood</subject><subject>Saquinavir</subject><subject>Saquinavir - blood</subject><subject>Saquinavir - pharmacokinetics</subject><subject>Saquinavir - therapeutic use</subject><subject>Zalcitabine</subject><subject>Zalcitabine - blood</subject><subject>Zalcitabine - pharmacokinetics</subject><subject>Zalcitabine - therapeutic use</subject><subject>Zidovudine</subject><subject>Zidovudine - blood</subject><subject>Zidovudine - pharmacokinetics</subject><subject>Zidovudine - therapeutic use</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk1v1DAQhi0EKkvhyg0pQogLzeLvxAcOq1UpSJW4wNma2E7jKolTO9nS_npcdrVqD4iTX3ued2bsMUJvCV4TQuvPAGbNSdZryhl7hlYEq7qUQsnnaIWxlCWvMX-JXqV0jfNeKHyCThSrCONyhZrz31NIS3RldGkKY3JFdD3MPsvOT6loQywS3Cx-hJ2PZ8W9t2G3WD-6swJGW9xDb_wMTT4o_FiYMGT511_MnYsw3b1GL1rok3tzWE_Rr6_nP7ffyssfF9-3m8sSRMXmklOQjFpniRVNaxgFBowSUlWydQ1WoAxpRVU3UjTWMqcwVBRDLWzT0Ioadoq-7PNOSzM4a9w4R-j1FP0A8U4H8PppZPSdvgo7TSQnnGT_x4M_hpvFpVkPPhnX9zC6sCRdKY4ZFuq_IJEid61kBtd70MSQUnTtsRmC9cP09Gaz1ZxkrR-mlw2f9gZIA9XXYYljfrF_0-8eX_iY_DDcHP9wiEMy0LcRRuPTEaNYcIFxxt7vsc5fdbc-Op2r6_yvHtf6Axdovdk</recordid><startdate>19971101</startdate><enddate>19971101</enddate><creator>VANHOVE, G. F</creator><creator>GRIES, J.-M</creator><creator>VEROTTA, D</creator><creator>SHEINER, L. B</creator><creator>COOMBS, R</creator><creator>COLLIER, A. C</creator><creator>BLASCHKE, T. F</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19971101</creationdate><title>Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy</title><author>VANHOVE, G. F ; GRIES, J.-M ; VEROTTA, D ; SHEINER, L. B ; COOMBS, R ; COLLIER, A. C ; BLASCHKE, T. F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a573t-42a632ded1d5bfc32a3a3211776feb09a9c1f578b65bdd3e90a720a85dbb272c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Anti-HIV Agents</topic><topic>Anti-HIV Agents - blood</topic><topic>Anti-HIV Agents - pharmacokinetics</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>CD4 Lymphocyte Count - drug effects</topic><topic>Clinical Trial</topic><topic>Clinical Trial, Phase II</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>HIV Infections</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - immunology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multicenter Study</topic><topic>Pharmacology. Drug treatments</topic><topic>Randomized Controlled Trial</topic><topic>Research Support, Non-U.S. Gov't</topic><topic>Research Support, U.S. Gov't, P.H.S</topic><topic>RNA, Viral - blood</topic><topic>Saquinavir</topic><topic>Saquinavir - blood</topic><topic>Saquinavir - pharmacokinetics</topic><topic>Saquinavir - therapeutic use</topic><topic>Zalcitabine</topic><topic>Zalcitabine - blood</topic><topic>Zalcitabine - pharmacokinetics</topic><topic>Zalcitabine - therapeutic use</topic><topic>Zidovudine</topic><topic>Zidovudine - blood</topic><topic>Zidovudine - pharmacokinetics</topic><topic>Zidovudine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VANHOVE, G. F</creatorcontrib><creatorcontrib>GRIES, J.-M</creatorcontrib><creatorcontrib>VEROTTA, D</creatorcontrib><creatorcontrib>SHEINER, L. B</creatorcontrib><creatorcontrib>COOMBS, R</creatorcontrib><creatorcontrib>COLLIER, A. C</creatorcontrib><creatorcontrib>BLASCHKE, T. F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VANHOVE, G. F</au><au>GRIES, J.-M</au><au>VEROTTA, D</au><au>SHEINER, L. B</au><au>COOMBS, R</au><au>COLLIER, A. C</au><au>BLASCHKE, T. F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>1997-11-01</date><risdate>1997</risdate><volume>41</volume><issue>11</issue><spage>2433</spage><epage>2438</epage><pages>2433-2438</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>9371346</pmid><doi>10.1128/aac.41.11.2433</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0066-4804 |
ispartof | Antimicrobial Agents and Chemotherapy, 1997-11, Vol.41 (11), p.2433-2438 |
issn | 0066-4804 1098-6596 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_164141 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Adult AIDS/HIV Anti-HIV Agents Anti-HIV Agents - blood Anti-HIV Agents - pharmacokinetics Anti-HIV Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Area Under Curve Biological and medical sciences CD4 Lymphocyte Count - drug effects Clinical Trial Clinical Trial, Phase II Dose-Response Relationship, Drug Drug Therapy, Combination Female HIV Infections HIV Infections - drug therapy HIV Infections - immunology Humans Male Medical sciences Middle Aged Multicenter Study Pharmacology. Drug treatments Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S RNA, Viral - blood Saquinavir Saquinavir - blood Saquinavir - pharmacokinetics Saquinavir - therapeutic use Zalcitabine Zalcitabine - blood Zalcitabine - pharmacokinetics Zalcitabine - therapeutic use Zidovudine Zidovudine - blood Zidovudine - pharmacokinetics Zidovudine - therapeutic use |
title | Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T19%3A53%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exposure-response%20relationships%20for%20saquinavir,%20zidovudine,%20and%20zalcitabine%20in%20combination%20therapy&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=VANHOVE,%20G.%20F&rft.date=1997-11-01&rft.volume=41&rft.issue=11&rft.spage=2433&rft.epage=2438&rft.pages=2433-2438&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/aac.41.11.2433&rft_dat=%3Cproquest_pubme%3E79403059%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16517796&rft_id=info:pmid/9371346&rfr_iscdi=true |